24 September 2015 in Scripta Scientifica Medica
INTRODUCTION: Cognitive impairment is frequent in multiple sclerosis and predominantly affects visuospatial abilities, memory, attention, and executive functions. Because of the specific cognitive profile, different from that in Alzheimer's disease and other frequent disorders presenting with dementia, specific neuropsychological instruments need to be used in multiple sclerosis. The aim of the present study is to assess the applicability of the Rey-Osterrieth complex figure test (ROCFT) for assessing cognitive impairment in patients with multiple sclerosis in comparison with a control group. MATERIAL AND METHODS: One hundred and two persons, 70 patients with MS and 32 healthy control subjects were assessed using ROCFT. A standardized system for assessment by points and percentiles was used. The results of both groups were compared statistically using independent samples t-test. RESULTS: On the copying task, the differences between patients and controls reached statistical significance, p<0.05 for the raw score, and p<0.001 after results were grouped by percentiles. On the drawing by memory task the differences between the two groups also showed statistical significance, p<0.01.CONCLUSION: ROCFT shows statistically significant differences between patients with multiple sclerosis and healthy subjects. Highest levels of significance were observed for copying, scored by percentiles, and for drawing by memory. The application of ROCFT can provide valuable information about cognitive dysfunction in multiple sclerosis.
5 April 2022 in Journal of Neuro-Oncology
5 March 2019 in Journal of IMAB – Annual Proceeding (Scientific Papers)
16 October 2017 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Background: The lack of a total numeric score of the CERAD neuropsychological battery may to some extent limit the possibilities for presenting the cognitive status and the degree of dementia. \ud The objective of the present study is to apply the CERAD battery in a Bulgarian population of demented and control subjects, to compute the total score for each participant, and to compare the performance of the two groups.\ud Methods: a total of 164 subjects, 134 patients with dementia and 30 controls were assessed using the Bulgarian version of the CERAD battery. The total score was calculated according to the method described by Chandler et al. Mean values were compared using independent samples t-test. ROC curves were built, and the area under the curve was calculated.\ud Results: The total score for the whole sample has a mean value of 63.45±20.56. After correction for age and education x=79.51±20.24. The total score is significantly lower in the demented subjects compared to the control group, for both raw and corrected score. The area under the ROC curve shows values of 0.988 and 0.986 before and after correction, respectively.\ud Conclusion: The statistically significant difference between the results of demented and control subjects, with and without correction for age and education, support the good applicability and high informative value of the instrument. The results of ROC analysis demonstrate the high value of the battery for diagnosing dementia
21 June 2018 in Journal of IMAB – Annual Proceeding (Scientific Papers)
21 June 2018 in Journal of IMAB – Annual Proceeding (Scientific Papers)